Another mitochondria-targeted antioxidant molecule, AntiOxCIN4, showed a significant cytoprotective effect in human hepatoma-derived (HepG2) cells through the NRF2–p62–KEAP1 axis [124]. Here, NFE2L2 is linked to hepatocellular carcinoma.